Skip to content

What is a 72 Hour Pain Injection? A Guide to Post-Surgical Relief

4 min read

Studies show that up to 80% of patients experience pain after surgery, with 75% of them reporting that pain as moderate to extreme [1.11.1]. So, what is a 72 hour pain injection and how can it help manage this common post-operative challenge?

Quick Summary

A 72-hour pain injection is a long-acting local anesthetic, most commonly the brand-name drug EXPAREL, administered during surgery to provide targeted pain relief for up to three days, potentially reducing the need for opioids [1.2.1, 1.3.1].

Key Points

  • What it is: A 72-hour pain injection is a long-acting, non-opioid local anesthetic, commonly the brand EXPAREL, given as a single dose during surgery [1.3.1, 1.3.2].

  • How it works: It uses a liposomal delivery system (DepoFoam®) to slowly release the anesthetic bupivacaine over 72 hours, blocking local pain signals [1.2.1, 1.9.1].

  • Primary Goal: To provide sustained pain relief during the most intense period of post-surgical recovery and significantly reduce or eliminate the need for opioid medications [1.4.2].

  • Administration: It is administered by a surgeon either directly into the surgical wound (local analgesia) or near a nerve bundle (regional nerve block) [1.5.1].

  • Key Benefits: Besides reducing opioid use, benefits include targeted pain control, convenience (one-time dose), and potentially faster recovery with fewer side effects like constipation and nausea [1.3.2, 1.3.4].

  • Common Uses: It is used in a wide array of procedures, including orthopedic, general, oral, and cosmetic surgeries [1.4.2].

  • Side Effects: The most common side effects are nausea, constipation, and vomiting. While rare, more serious risks exist, such as systemic reactions and a blood disorder called methemoglobinemia [1.4.2, 1.6.3].

In This Article

Understanding the 72-Hour Pain Injection

A "72-hour pain injection" refers to a long-acting, non-opioid local anesthetic administered as a single dose by a doctor during a surgical procedure [1.3.1]. The most common medication used for this purpose is EXPAREL® (bupivacaine liposome injectable suspension) [1.3.2]. It is designed to manage pain in the initial, most intense days following surgery, helping to reduce reliance on opioid medications [1.2.1, 1.4.2].

This medication is not a systemic painkiller that affects the entire body; instead, it works locally at the surgical site [1.4.2]. It can be administered in two primary ways:

  • Local Analgesia: Injected directly into the soft tissues and wound site of the surgery [1.4.5]. This is approved for adults and children aged 6 years and older [1.5.3].
  • Regional Nerve Block: Injected near specific nerves to block pain signals from an entire region of the body, such as the shoulder, arm, or leg [1.5.1]. This is approved for adults for specific blocks like the interscalene brachial plexus, sciatic nerve in the popliteal fossa, and adductor canal block [1.5.3].

The Science Behind Long-Lasting Relief

The active ingredient in EXPAREL is bupivacaine, a common local anesthetic [1.4.5]. The key to its long-lasting effect is its unique delivery system. The bupivacaine is encapsulated within multivesicular liposomes, which are like tiny, fat-based bubbles [1.2.1, 1.5.5]. This formulation is known as DepoFoam® technology [1.3.4].

After injection, these liposomes slowly break down and release the bupivacaine medication over an extended period [1.9.1]. This gradual release blocks the nerve endings at the surgical site from sending pain signals to the brain, providing sustained pain relief for up to 72 hours [1.2.1, 1.9.4]. Standard bupivacaine, by contrast, typically only lasts for about 8 hours [1.3.4].

Common Uses and Procedures

The 72-hour pain injection is utilized across a wide range of surgical procedures to improve the patient's recovery experience [1.4.2]. Its opioid-sparing benefits make it a valuable tool in many specialties.

Common surgical applications include:

  • Orthopedic Surgery: Total knee and hip arthroplasty, shoulder surgery (e.g., rotator cuff repair), and ankle procedures [1.2.1, 1.4.2].
  • Soft Tissue and General Surgery: Hernia repair, hemorrhoidectomy, and colectomy [1.2.1, 1.4.2].
  • Oral and Maxillofacial Surgery: Wisdom tooth extractions and dental implant surgery [1.2.3, 1.9.4].
  • Women's Health: Hysterectomy, C-sections, and breast augmentation [1.2.1, 1.4.2].
  • Cosmetic Surgery: Bunionectomy and abdominoplasty (tummy tuck) [1.2.1, 1.4.5].

Benefits of Choosing a Long-Acting Injection

The primary advantage of using a 72-hour injection like EXPAREL is the significant reduction in the need for post-operative opioids [1.4.2]. This helps patients avoid the common and undesirable side effects of narcotics, such as nausea, vomiting, constipation, drowsiness, and the risk of dependence [1.3.2].

Other key benefits include:

  • Sustained, Targeted Pain Control: Provides relief directly at the source of the pain during the most critical recovery period [1.4.4, 1.9.4].
  • Convenience: A single dose is administered by the surgeon during the procedure, eliminating the need for patients to manage a complex schedule of pain pills [1.3.5].
  • Improved Patient Satisfaction: Patients often report greater satisfaction with their post-operative recovery [1.3.2].
  • Potentially Shorter Hospital Stays: Effective pain control can contribute to faster recovery and ambulation, which may lead to shorter hospital stays compared to opioid-based regimens [1.3.4].

Potential Risks and Side Effects

Like any medication, EXPAREL has potential side effects. The most common adverse reactions are generally mild and can also be associated with surgery itself [1.4.3]. Common side effects reported in 10% or more of adult patients include nausea, constipation, and vomiting [1.6.4]. When used as a nerve block, fever and headache may also occur [1.4.2].

While rare, more serious side effects can occur and require immediate medical attention:

  • Systemic Reaction: The anesthetic can affect the central nervous system and cardiovascular system, causing symptoms like drowsiness, confusion, metallic taste, ringing in the ears, or changes in heart rate [1.6.3].
  • Methemoglobinemia: A serious blood disorder where the blood's ability to carry oxygen is reduced. Symptoms include pale, gray, or blue-colored skin, shortness of breath, and rapid heart rate [1.6.3, 1.6.5].
  • Allergic Reactions: Hives, itching, difficulty breathing, or swelling of the face, lips, or throat [1.5.4].

It's important to note that EXPAREL should not be injected into joints, as it can be toxic to cartilage cells [1.3.4, 1.4.1].

Comparison: 72-Hour Injection vs. Other Pain Management Methods

Feature 72-Hour Injection (EXPAREL) Traditional Nerve Block Oral Opioids Pain Pump/Catheter
Mechanism Single injection of slow-release local anesthetic at the surgical site [1.9.1]. Single injection of standard local anesthetic near a nerve bundle. Systemic medication that affects the entire body and brain [1.4.2]. Catheter placed near the surgical site continuously infuses local anesthetic [1.3.4].
Duration Up to 72-96 hours from one dose [1.2.1, 1.3.3]. Typically less than 24 hours. 4-6 hours per dose, requiring repeated administration. Continuous, as long as the pump is running.
Administration By the surgeon during the procedure [1.3.1]. By an anesthesiologist, often before surgery. Self-administered by the patient after surgery. Placed by a surgeon; requires managing the external pump [1.4.5].
Primary Benefit Long-lasting, non-opioid pain control from a single dose [1.4.2]. Strong, targeted regional numbness. Strong pain relief. Continuous, localized pain relief.
Key Drawback Higher upfront drug cost; risk of localized numbness [1.7.3]. Shorter duration; potential for falls or motor weakness [1.10.2]. Systemic side effects (nausea, constipation, addiction risk) [1.3.2]. Risk of catheter dislodgement, infection, and tissue necrosis [1.3.4].

Conclusion

The 72-hour pain injection, primarily known as EXPAREL, represents a significant advancement in post-operative pain management. By providing up to three days of targeted, non-opioid pain relief from a single dose administered during surgery, it offers a powerful tool for improving patient comfort and recovery [1.2.1, 1.3.2]. Its ability to reduce or eliminate the need for opioids helps patients avoid a host of negative side effects and contributes to a smoother, more satisfying recovery experience [1.3.4]. While it has its own set of risks and costs, its benefits have made it an integral part of modern, multimodal pain control strategies for a wide variety of surgical procedures [1.4.2].


An authoritative outbound link for further reading: EXPAREL® (bupivacaine liposome injectable suspension) Official Patient Site

Frequently Asked Questions

No, it is not an opioid. It is a local anesthetic (bupivacaine) that works by numbing the surgical area, unlike opioids which affect the entire body and have a risk of dependence [1.4.5].

The injection is designed to significantly reduce the need for other pain medications, especially opioids. Some patients may not need any other pain relievers, while others might be prescribed a combination to manage any breakthrough pain [1.2.3, 1.4.3].

The pain relief can last for up to 72 hours (3 days), but you may experience temporary loss of sensation or movement in the injected area for up to 5 days [1.2.1, 1.3.3].

The most frequently reported side effects in adults include nausea, constipation, and vomiting [1.4.2]. These are also common side effects of surgery and anesthesia in general.

A doctor or surgeon administers the injection directly into the surgical site or as a nerve block during your procedure [1.3.1]. You will not receive a prescription to fill or administer it yourself.

Many insurance plans, including Aetna, may consider EXPAREL medically necessary for specific uses like post-surgical infiltration and certain nerve blocks [1.5.2]. Coverage can vary, so it is best to discuss it with your doctor and insurance provider.

Yes, EXPAREL is approved for local analgesia (injection into the wound) in children aged 6 years and older [1.5.3]. However, it is not currently recommended for nerve blocks in patients younger than 18 [1.4.2].

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.